Study ID: 9006
Study Title
- A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxoneֲ® Compared to Copaxoneֲ® 20mg, the Currently Approved Dose
Teva Identifier
- 9006
ClinicalTrials.gov Identifier
- NCT00202982
Study Status
- Completed
Trial Condition(s)
- Relapse-Remitting Multiple Sclerosis
Interventions
- Drug: glatiramer acetate 20 mg | Drug: glatiramer acetate 40 mg
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 50 Years
Trial Duration
- 08/01/2003 - 09/01/2005
Phase
- Phase 2
Study Type
Interventional
